Add to ORKGIT IS DESCRIBED THE ROLE OF AN ADOPTIVE IMMUNOTHERAPY WITH RECOMBINANT IL-2 AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION (ABMT) FOR HIGH RISK NEUROBLASTOMA (HR-NB
Immune monitoring and adoptive immunotherapy following allogeneic hematopoietic stem cell transplant...
Autologous stem cell transplantation (ASCT) for the treatment of high-risk neuroblastoma (NBL) is an...
Although dose intensification of chemotherapy has increased initial response rates in neuroblastoma ...
IT IS DESCRIBED THE ROLE OF AN ADOPTIVE IMMUNOTHERAPY WITH RECOMBINANT IL-2 AFTER AUTOLOGOUS BONE MA...
Background Neuroblastoma is a rare malignant disease that primarily affects children. The tumours ma...
The purpose of this study was to evaluate in a phase I-II trial whether low doses of recombinant hum...
The purpose of this study was to evaluate in a phase I-II trial whether low doses of recombinant hum...
The purpose of this study was to evaluate in a phase I-II trial whether low doses of recombinant hum...
The purpose of this study was to evaluate in a phase I-II trial whether low doses of recombinant hum...
High-dose chemotherapy followed by autologous bone marrow transplantation (ABMT) in the treatment of...
Management for high-risk neuroblastoma (NBL) has included autologous hematopoietic stem cell transpl...
Allogeneic bone marrow transplantation (BMT) has been increasingly used for the treatment of both ne...
High-risk neuroblastomas (HR-NB) still have an unacceptable 5-year overall survival despite the aggr...
AbstractMyeloablative chemotherapy or radiation therapy supported by autologous stem cell transplant...
Haploidentical stem cell transplantation (haplo SCT) in Stage IV neuroblastoma relapsed patients has...
Immune monitoring and adoptive immunotherapy following allogeneic hematopoietic stem cell transplant...
Autologous stem cell transplantation (ASCT) for the treatment of high-risk neuroblastoma (NBL) is an...
Although dose intensification of chemotherapy has increased initial response rates in neuroblastoma ...
IT IS DESCRIBED THE ROLE OF AN ADOPTIVE IMMUNOTHERAPY WITH RECOMBINANT IL-2 AFTER AUTOLOGOUS BONE MA...
Background Neuroblastoma is a rare malignant disease that primarily affects children. The tumours ma...
The purpose of this study was to evaluate in a phase I-II trial whether low doses of recombinant hum...
The purpose of this study was to evaluate in a phase I-II trial whether low doses of recombinant hum...
The purpose of this study was to evaluate in a phase I-II trial whether low doses of recombinant hum...
The purpose of this study was to evaluate in a phase I-II trial whether low doses of recombinant hum...
High-dose chemotherapy followed by autologous bone marrow transplantation (ABMT) in the treatment of...
Management for high-risk neuroblastoma (NBL) has included autologous hematopoietic stem cell transpl...
Allogeneic bone marrow transplantation (BMT) has been increasingly used for the treatment of both ne...
High-risk neuroblastomas (HR-NB) still have an unacceptable 5-year overall survival despite the aggr...
AbstractMyeloablative chemotherapy or radiation therapy supported by autologous stem cell transplant...
Haploidentical stem cell transplantation (haplo SCT) in Stage IV neuroblastoma relapsed patients has...
Immune monitoring and adoptive immunotherapy following allogeneic hematopoietic stem cell transplant...
Autologous stem cell transplantation (ASCT) for the treatment of high-risk neuroblastoma (NBL) is an...
Although dose intensification of chemotherapy has increased initial response rates in neuroblastoma ...